Nephros, Inc.
NEPH
$3.58
$0.113.17%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.12% | 1,513.51% | 259.42% | 202.55% | 155.70% |
| Total Depreciation and Amortization | -11.89% | 1.46% | -7.19% | -19.89% | -26.29% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -18.06% | -14.81% | -32.57% | -34.09% | -39.02% |
| Change in Net Operating Assets | -50.81% | 73.42% | 111.07% | 68.77% | -384.59% |
| Cash from Operations | -169.32% | 434.35% | 233.74% | 335.50% | 514.88% |
| Capital Expenditure | -- | -- | 100.00% | 100.00% | 26.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | -100.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 100.00% | 100.00% | 33.33% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -25.00% | 0.00% | 28.57% | 57.14% | 42.86% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 7,225.00% | 0.00% | 28.57% | 57.14% | 42.86% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -114.06% | 399.82% | 225.36% | 303.47% | 320.69% |